International audienceImprovement of anticancer treatments is associated with increased survival of cancer patients at risk of cardiac disease. Therefore, there is an urgent need for new therapeutic molecules capable of preventing acute and long-term cardiotoxicity. Here, using commercial and home-made chemolibraries, we performed a robust phenotypic high-throughput screening in rat cardiomyoblast cell line H9c2, searching for small molecules capable of inhibiting cell death. A screen of 1600 compounds identified six molecules effective in preventing necrosis and apoptosis induced by H$_2$O$_2$ and camptothecin in H9c2 cells and in rat neonatal ventricular myocytes. In cells treated with these molecules, we systematically evaluated the expr...
Several front-line chemotherapeutics cause mitochondria-derived, oxidative stress-mediated cardiotox...
Although treatment for heart failure induced by cancer therapy has improved in recent years, the pre...
Despite advances in supportive and protective therapy for myocardial function, heart failure caused ...
International audienceImprovement of anticancer treatments is associated with increased survival of ...
Improvement of anticancer treatments is associated with increased survival of cancer patients at ris...
Antracyclines are effective antitumor agents. One of the most commonly used antracyclines is doxorub...
Cardiotoxicity is a major drawback of anticancer therapies, often hindering optimal management of ca...
Autophagy is an evolutionarily conserved intracellular mechanism for degradation of long-lived prote...
In recent years, apoptosis has increasingly drawn the attention of both oncologists and cardiologist...
Apoptosis, or programmed cell death, is a highly conserved process used by multicellular organisms t...
In recent years, apoptosis has increasingly drawn the attention of both oncologists and cardiologist...
Chemotherapy-induced impairment of autophagy is implicated in cardiac toxicity induced by anti-cance...
Copyright © 2018 American Chemical Society. Clinically approved therapeutics that mitigate chemother...
Based on growing evidence linking autophagy to preconditioning, we tested the hypothesis that autoph...
<div><p>Several front-line chemotherapeutics cause mitochondria-derived, oxidative stress-mediated c...
Several front-line chemotherapeutics cause mitochondria-derived, oxidative stress-mediated cardiotox...
Although treatment for heart failure induced by cancer therapy has improved in recent years, the pre...
Despite advances in supportive and protective therapy for myocardial function, heart failure caused ...
International audienceImprovement of anticancer treatments is associated with increased survival of ...
Improvement of anticancer treatments is associated with increased survival of cancer patients at ris...
Antracyclines are effective antitumor agents. One of the most commonly used antracyclines is doxorub...
Cardiotoxicity is a major drawback of anticancer therapies, often hindering optimal management of ca...
Autophagy is an evolutionarily conserved intracellular mechanism for degradation of long-lived prote...
In recent years, apoptosis has increasingly drawn the attention of both oncologists and cardiologist...
Apoptosis, or programmed cell death, is a highly conserved process used by multicellular organisms t...
In recent years, apoptosis has increasingly drawn the attention of both oncologists and cardiologist...
Chemotherapy-induced impairment of autophagy is implicated in cardiac toxicity induced by anti-cance...
Copyright © 2018 American Chemical Society. Clinically approved therapeutics that mitigate chemother...
Based on growing evidence linking autophagy to preconditioning, we tested the hypothesis that autoph...
<div><p>Several front-line chemotherapeutics cause mitochondria-derived, oxidative stress-mediated c...
Several front-line chemotherapeutics cause mitochondria-derived, oxidative stress-mediated cardiotox...
Although treatment for heart failure induced by cancer therapy has improved in recent years, the pre...
Despite advances in supportive and protective therapy for myocardial function, heart failure caused ...